肾移植后三发性甲状旁腺功能亢进:甲状旁腺切除术与西那卡塞对移植肾功能的影响
该荟萃分析评估肾移植后三发性甲状旁腺功能亢进患者接受甲状旁腺切除术或西那卡塞治疗后移植肾功能的变化。共纳入18项研究进行统计分析,结果显示两种治疗均未显著改变血清肌酐和估算肾小球滤过率,但研究间存在显著异质性。
要点
- 甲状旁腺切除术与西那卡塞均未显著损害移植肾功能
- 研究间异质性显著,部分源于三发性甲状旁腺功能亢进缺乏共识定义
- 两种治疗对移植肾功能影响的研究证据仍有限
核心结论
- 荟萃分析显示甲状旁腺切除术和西那卡塞均不会显著损害三发性甲状旁腺功能亢进患者的移植肾功能。
- 研究间存在显著异质性,部分由三发性甲状旁腺功能亢进缺乏共识定义解释,限制了所有已发表系列研究的结论。
研究设计与样本
- 通过Pubmed、Embase和Cochrane数据库检索,遵循PRISMA报告指南进行荟萃分析。
- 68项研究经筛选后,18项无缺失数据的研究纳入统计分析。
- 采用随机效应荟萃分析评估血清肌酐和估算肾小球滤过率的变化。
主要发现
- 甲状旁腺切除术后血清肌酐无显著变化(6项研究,314例患者)。
- 甲状旁腺切除术后估算肾小球滤过率无显著变化(2项研究,105例患者)。
- 西那卡塞给药后血清肌酐无显著变化(10项研究,404例患者)。
- 西那卡塞给药后估算肾小球滤过率无显著变化(6项研究,149例患者)。
- 研究间存在显著异质性(P < .01,Cochran's Q)。
临床怎么用
- 对于肾移植后三发性甲状旁腺功能亢进患者,甲状旁腺切除术或西那卡塞治疗均未显示显著损害移植肾功能。
- 临床决策时需考虑研究间显著异质性及三发性甲状旁腺功能亢进定义缺乏共识的局限。
局限性
- 研究间存在显著异质性(P < .01,Cochran's Q)。
- 三发性甲状旁腺功能亢进缺乏共识定义,部分解释了异质性。
- 异质性限制了所有已发表系列研究的结论。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Tertiary hyperparathyroidism occurs in 25% to 50% of kidney-transplanted patients. Indication of parathyroidectomy is now discussed, since the calcimimetic agent, cinacalcet, is an alternate option. The effects of either of these treatments on graft function remain controversial, studied only in small cohorts showing either decrease or absence of modification. We performed a meta-analysis to evaluate the evolution of graft function after surgical or medical treatment. METHODS: Studies assessing graft function in tertiary hyperparathyroidism after parathyroidectomy or cinacalcet introduction were enrolled into quantitative analysis using Pubmed, Embase, and Cochrane databases following the Preferred Reporting Items for Systematic Reviews and Meta-Analysis reporting guidelines. Among 68 screened studies, 18 had no missing data and were included for statistical analyses. We performed random effect meta-analysis to determine changes in serum creatinine and estimated glomerular filtration rate. RESULTS: Seven studies assessing the evolution of graft function 6 and/or 12 months after parathyroidectomy and 13 after administration of cinacalcet were included. Meta-analysis found no significant variations after parathyroidectomy in serum creatinine (6 studies, 314 patients) and estimated glomerular filtration rate (2 studies, 105 patients). No significant variation was found after administration of cinacalcet in serum creatinine (10 studies, 404 patients) and estimated glomerular filtration rate (6 studies, 149 patients). A significant heterogeneity between the studies (P < .01, Cochran's Q) was found. CONCLUSION: Meta-analysis shows that parathyroidectomy and cinacalcet do not significantly impair graft function in patients with tertiary hyperparathyroidism. However, the significant heterogeneity between selected studies, partially explained by the lack of consensual definition of tertiary hyperparathyroidism, limits the conclusions of all previously published series.
引用
- Frey S, Goronflot T, Kerleau C, et al. Parathyroidectomy or cinacalcet: Do we still not know the best option for graft function in kidney-transplanted patients? A meta-analysis. Surgery. 2021. PMID: 33810851. doi:10.1016/j.surg.2021.02.048
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。